Nucleolin antagonist triggers autophagic cell death in human glioblastoma primary cells and decreased in vivo tumor growth in orthotopic brain tumor model

Nucleolin (NCL) is highly expressed in several types of cancer and represents an interesting therapeutic target. It is expressed at the plasma membrane of tumor cells, a property which is being used as a marker for several human cancer including glioblastoma. In this study we investigated targeting...

詳細記述

保存先:
書誌詳細
出版年:Oncotarget
主要な著者: Benedetti, Elisabetta, Antonosante, Andrea, d'Angelo, Michele, Cristiano, Loredana, Galzio, Renato, Destouches, Damien, Florio, Tiziana Marilena, Dhez, Anne Chloé, Astarita, Carlo, Cinque, Benedetta, Fidoamore, Alessia, Rosati, Floriana, Cifone, Maria Grazia, Ippoliti, Rodolfo, Giordano, Antonio, Courty, José, Cimini, Annamaria
フォーマット: Artigo
言語:Inglês
出版事項: Impact Journals LLC 2015
主題:
Research Paper
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4747212/
https://ncbi.nlm.nih.gov/pubmed/26540346
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料